Pregnant Obese Women and Fetal Ultrasound Quality. (EPOWUS)

January 2, 2025 updated by: University Hospital, Clermont-Ferrand

Echography in Pregnant Obese Women and Ultrasound Speed.

Ultrasound (US) image construction uses equations that contain the value of the propagation velocity of sound waves; this velocity is assumed conventionally to be constant and equal to 1540 m/s in the human body. Since 1977, all manufacturers of US scanners have used this value, which was first established in 1950. In fatty tissue, however, the actual propagation velocity is only in the order of 1450 m/s. US velocity in fat tissue is slower than in other soft tissues (ie:1450 m/s vs 1540 m/s) therefore the intrinsic image quality in terms of sharpness and precision is improved when considering this parameter for image construction The main objective of this study is to evaluate the impact of ultrasound propagation velocity setting on completeness of ultrasound exams and images quality during the second and third trimester fetal ultrasound examination in obese patients.

Study Overview

Detailed Description

Obese pregnant women will be included before the second trimester fetal ultrasound examination.

Women will be allocated to one intervention group or to the control group. In the intervention group, the ultrasonographer will be able to use several ultrasound propagation velocities to perform the exam.

In the control group, exam will be performed using the conventional ultrasound velocity.

An exam will be considered to be complete if all the images recommended by national guideline are acquired. If ultrasound images are missing, other ultrasound exams may be performed until completeness is reached.

The protocol will be applied for the second and the third fetal ultrasound examination which are recommended by national guideline.

All scans will be evaluated by two independent experts who do not have performed any of the exams. They will evaluate the completeness of each exam. Each scan will be quoted using the quality score proposed by Salomon et al.

Study Type

Interventional

Enrollment (Actual)

596

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Clermont-Ferrand, France, 63000
        • Hôpital Estaing - Centre Hospitalier Universitaire de Clermont-Ferrand
      • Lyon, France
        • Hôpital de la croix Rousse - Hospices Civils de Lyon
      • Lyon, France
        • Hôpital Femme Mére Enfant - Hospices Civils de Lyon
      • Montpellier, France
        • Hôpital Arnaud de Villeneuve - CHU de Montpellier
      • Paris, France
        • Hôpital Cochin - Assistance Publique - Hôpitaux de Paris

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Body mass index>30
  • Between 20 and 25 weeks of gestation

Exclusion Criteria:

  • Multiple pregnancy
  • Uterine scare

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: free ultrasound propagation velocity
ultrasound exams will be performed using several ultrasound propagation velocities

Obese pregnant women will be included before the second trimester fetal ultrasound examination.

Women will be allocated to one intervention group or to the control group. In the intervention group, the ultrasonographer will be able to use several ultrasound propagation velocities to perform the exam.

In the control group, exam will be performed using the conventional ultrasound velocity.

An exam will be considered to be complete if all the images recommended by national guideline are acquired. If ultrasound images are missing, other ultrasound exams may be performed until completeness is reached.

The protocol will be applied for the second and the third fetal ultrasound examination which are recommended by national guideline.

All scans will be evaluated by two independent experts who do not have performed any of the exams. They will evaluate the completeness of each exam. Each scan will be quoted using the quality score proposed by Salomon et al.

No Intervention: conventional ultrasound propagation velocity
ultrasound exams will be performed using the 1540m/s conventional celerity

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
image quality of fetal ultrasound exam
Time Frame: second trimester and third trimester ultrasound exam
Quality will be assessed by calculating Salomon's score for each image.
second trimester and third trimester ultrasound exam
completeness of fetal ultrasound exam
Time Frame: second trimester and third trimester ultrasound exam
completeness will be assessed by the number of the recommended images which could have been registered during the first ultrasound exam in each trimester.
second trimester and third trimester ultrasound exam

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
use of supplementary ultrasound exams in order to assess completeness
Time Frame: through study completion, an average of 1 year
description of each modality of supplemental ultrasound exam
through study completion, an average of 1 year
description of ultrasonographist method in order to improve ultrasound exam
Time Frame: through study completion, an average of 1 year
description of modality
through study completion, an average of 1 year
economic analysis of the intervention
Time Frame: through study completion, an average of 1 year
cost-effectiveness analysis
through study completion, an average of 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Amélie Delabaere, MD, PhD, CHU de Clermont-Ferrand

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 2, 2019

Primary Completion (Actual)

October 19, 2024

Study Completion (Actual)

October 19, 2024

Study Registration Dates

First Submitted

August 30, 2019

First Submitted That Met QC Criteria

December 24, 2019

First Posted (Actual)

December 26, 2019

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 2, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • PHRC IR 2018 DELABAERE
  • 2018-A03478-47 (Other Identifier: ANSM)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pregnant Women

Clinical Trials on ultrasound propagation velocities, ultrasound fetal quality

Subscribe